Literature DB >> 3456066

Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies.

E E McConnell, H A Solleveld, J A Swenberg, G A Boorman.   

Abstract

In a continuing review of long-term toxicology and carcinogenesis studies in rats and mice, the National Toxicology Program (NTP) is confronted with many problems concerning the interpretation of tumor data. A frequently raised question is: "Should certain neoplasms be combined for overall assessment of rodent carcinogenesis data?" NTP policy is that certain neoplasms may be combined for statistical assessment of tumor data and that hyperplastic responses may be used as supportive evidence. The primary reason for combining neoplastic lesions is to gain more insight into the evidence of the carcinogenicity of a given chemical in that species of animal. This report gives the rationale, criteria, and guidelines used by the NTP for combining neoplasms for the evaluation of long-term rodent toxicology and carcinogenesis studies. The guidelines are based mainly on lesions occurring in the F344/N inbred rat and (C57BL/6 X C3H)F1 mouse and may or may not be appropriate for other strains or species. The concepts of combining neoplasms and sites should be viewed in terms of the study as a whole, since tumor formation is only one of many responses caused by chemicals in mammals. The resulting information becomes part of the "weight of the evidence" for estimating the potential hazard of a given chemical.

Entities:  

Mesh:

Year:  1986        PMID: 3456066

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  20 in total

1.  DETERMINING DISEASE CAUSALITY FROM EXPERIMENTAL TOXICOLOGY STUDIES.

Authors:  Ronald L Melnick; John R Bucher
Journal:  J Law Policy       Date:  2005

2.  O-aminoazotoluene suppresses hepatocyte proliferation in inbred mice susceptible to hepatocarcinogenesis.

Authors:  A V Eremeev; O A Timofeeva; A V Goloshchapov; S I Il'nitskaya; T I Merkulova; V I Kaledin; N A Setkov
Journal:  Dokl Biol Sci       Date:  2009 Sep-Oct

Review 3.  Incretin therapy--present and future.

Authors:  Alan J Garber
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 4.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

Authors:  J Penston; K G Wormsley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

5.  Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphosate-resistant genetically modified maize NK603 in Wistar Han RCC rats.

Authors:  Pablo Steinberg; Hilko van der Voet; Paul W Goedhart; Gijs Kleter; Esther J Kok; Maria Pla; Anna Nadal; Dagmar Zeljenková; Radka Aláčová; Júlia Babincová; Eva Rollerová; Soňa Jaďuďová; Anton Kebis; Elena Szabova; Jana Tulinská; Aurélia Líšková; Melinda Takácsová; Miroslava Lehotská Mikušová; Zora Krivošíková; Armin Spök; Monica Racovita; Huib de Vriend; Roger Alison; Clare Alison; Wolfgang Baumgärtner; Kathrin Becker; Charlotte Lempp; Marion Schmicke; Dieter Schrenk; Annette Pöting; Joachim Schiemann; Ralf Wilhelm
Journal:  Arch Toxicol       Date:  2019-02-12       Impact factor: 5.153

6.  Investigation of potential oncogenetic effects of beta-cyclodextrin in the rat and mouse.

Authors:  T Waner; G Borelli; S Cadel; I Privman; A Nyska
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 7.  Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies.

Authors:  J E Huff; S L Eustis; J K Haseman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

8.  Perinatal toxicity and carcinogenicity studies of styrene-acrylonitrile trimer, a ground water contaminant.

Authors:  Mamta Behl; Susan A Elmore; David E Malarkey; Milton R Hejtmancik; Diane K Gerken; Rajendra S Chhabra
Journal:  Toxicology       Date:  2013-09-20       Impact factor: 4.221

9.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

10.  Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure.

Authors:  Matthew D Stout; Ronald A Herbert; Grace E Kissling; Bradley J Collins; Gregory S Travlos; Kristine L Witt; Ronald L Melnick; Kamal M Abdo; David E Malarkey; Michelle J Hooth
Journal:  Environ Health Perspect       Date:  2008-12-31       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.